Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06720272 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

School-based Program for the Prevention of Rheumatic Heart Disease in Endemic Regions

Study acronym: PREVENT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall objective of the PREVENT trial is to evaluate the effectiveness of an integrated, school-based program for the prevention of rheumatic heart disease (RHD) in regions with an endemic pattern of RHD. We conduct a stepped wedge cluster randomized trial in randomly selected schools in Nepal and Zambia. The intervention will be delivered at the level of the school and consists in the introduction of a dedicated school-nurse program providing health care through education about RHD, assessment, intervention, and follow-up of GABHS pharyngitis, and facilitation of secondary antibiotic prophylaxis for children with RHD.
Trial Details
NCT Number NCT06720272
Lead Sponsor Thomas Pilgrim
Collaborators: Centre for Infectious Disease Research in Zambia, National Academy of Medical Sciences, Nepal, University of Oxford
Conditions
(from sponsor)		 Rheumatic Heart Disease in Children
Related terms Heart Valve Diseases, Rheumatic Fever, Rheumatic Heart Disease
Enrollment 6,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov